ArticleCancer genomics & proteomics

PRIM2: A Marker of MYC-driven Hyper-proliferation, Disease Progression, Tumor Aggressiveness and Poor Survival in Glioma Patients.

Ronghui Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.